Over the past 12 months, 3 insiders at BioCardia, Inc. filed 30 open-market SEC Form 4 transactions on BCDA: 30 purchases worth $1.1M and 0 sales worth $0. Insiders have been net buyers over this period. The most recent filing was on Jul 15, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 15, 26 | Peter AltmanPresident and CEO, Director | BUY | 1.5K | $0.86 | $1K |
| Jul 14, 26 | Peter AltmanPresident and CEO, Director | BUY | 2.8K | $0.88 | $2K |
| Jul 10, 26 | Peter AltmanPresident and CEO | BUY | 1.0K | $0.94 | $940 |
| Jul 9, 26 | Peter AltmanPresident and CEO | BUY | 1.0K | $0.90 | $900 |
| Jul 8, 26 | Peter AltmanPresident and CEO | BUY | 5.5K | $0.97 | $5K |
| Jun 23, 26 | Simon H Stertzer | BUY | 39.0K | $1.00 | $39K |
| Jun 22, 26 | Simon H Stertzer | BUY | 70.2K | $0.92 | $65K |
| Jun 18, 26 | Peter AltmanPresident and CEO | BUY | 800 | $0.96 | $768 |
| Jun 17, 26 | Peter AltmanPresident and CEO | BUY | 1.5K | $0.85 | $1K |
| Jun 9, 26 | Peter AltmanPresident and CEO | BUY | 5.0K | $0.85 | $4K |
| May 20, 26 | Peter AltmanPresident and CEO | BUY | 1.5K | $0.92 | $1K |
| May 18, 26 | Peter AltmanPresident and CEO | BUY | 5.7K | $0.92 | $5K |
| May 15, 26 | Peter AltmanPresident and CEO | BUY | 5.1K | $1.02 | $5K |
| Apr 29, 26 | Peter AltmanPresident and CEO | BUY | 5.0K | $1.11 | $6K |
| Apr 20, 26 | Peter AltmanPresident and CEO | BUY | 600 | $1.23 | $738 |
| Mar 25, 26 | Peter AltmanPresident and CEO | BUY | 300 | $1.22 | $366 |
| Mar 24, 26 | Peter AltmanPresident and CEO | BUY | 600 | $1.24 | $744 |
| Feb 4, 26 | Peter AltmanPresident and CEO | BUY | 5.0K | $1.13 | $6K |
| Jan 21, 26 | Peter AltmanPresident and CEO | BUY | 300 | $1.34 | $402 |
| Jan 20, 26 | Peter AltmanPresident and CEO | BUY | 600 | $1.32 | $792 |
| Dec 17, 25 | Peter AltmanPresident and CEO | BUY | 900 | $1.30 | $1K |
| Dec 16, 25 | Peter AltmanPresident and CEO | BUY | 200 | $1.37 | $274 |
| Sep 19, 25 | Peter AltmanPresident and CEO | BUY | 48.0K | $1.25 | $60K |
| Sep 19, 25 | Andrew Scott BlankDirector | BUY | 288.0K | $1.25 | $360K |
| Sep 19, 25 | Simon H StertzerDirector | BUY | 398.4K | $1.25 | $498K |
| Aug 22, 25 | Peter AltmanPresident and CEO | BUY | 700 | $1.83 | $1K |
| Aug 13, 25 | Peter AltmanPresident and CEO | BUY | 100 | $1.83 | $183 |
| Aug 12, 25 | Peter AltmanPresident and CEO | BUY | 400 | $1.75 | $700 |
| Aug 11, 25 | Peter AltmanPresident and CEO | BUY | 1.7K | $1.76 | $3K |
| Jun 30, 25 | Peter AltmanPresident and CEO | BUY | 24.1K | $2.08 | $50K |
| Jun 30, 25 | Andrew Scott BlankDirector | BUY | 72.3K | $2.08 | $150K |
| Jun 30, 25 | David McClungChief Financial Officer | BUY | 4.8K | $2.08 | $10K |
| Jun 30, 25 | Simon H StertzerDirector | BUY | 72.3K | $2.08 | $150K |
| May 30, 25 | Peter AltmanPresident and CEO | BUY | 100 | $2.21 | $221 |
| May 22, 25 | Peter AltmanPresident and CEO | BUY | 700 | $1.89 | $1K |
| May 20, 25 | Peter AltmanPresident and CEO | BUY | 1.6K | $2.08 | $3K |
| May 16, 25 | Peter AltmanPresident and CEO | BUY | 300 | $2.43 | $729 |
| May 14, 25 | Peter AltmanPresident and CEO | BUY | 100 | $2.99 | $299 |
| Apr 23, 25 | Peter AltmanPresident and CEO | BUY | 26.2K | $1.91 | $50K |
| Apr 23, 25 | Andrew Scott BlankDirector | BUY | 131.2K | $1.91 | $251K |
| Apr 23, 25 | Bill FacteauDirector | BUY | 13.1K | $1.91 | $25K |
| Apr 23, 25 | Richard M KrasnoDirector | BUY | 13.1K | $1.91 | $25K |
| Apr 23, 25 | David McClungChief Financial Officer | BUY | 13.1K | $1.91 | $25K |
| Apr 23, 25 | Simon H StertzerDirector | BUY | 105.0K | $1.91 | $201K |
| Apr 15, 25 | Peter AltmanPresident and CEO | BUY | 100 | $2.14 | $214 |
| Apr 11, 25 | Peter AltmanPresident and CEO | BUY | 300 | $2.03 | $609 |
| Apr 10, 25 | Peter AltmanPresident and CEO | BUY | 300 | $1.99 | $597 |
| Apr 7, 25 | Peter AltmanPresident and CEO | BUY | 500 | $1.96 | $980 |
| Apr 4, 25 | Peter AltmanPresident and CEO | BUY | 800 | $2.04 | $2K |
| Apr 3, 25 | Peter AltmanPresident and CEO | BUY | 1.2K | $2.24 | $3K |
Over the past 12 months, insiders at BioCardia, Inc. filed 30 open-market purchases worth $1.1M and 0 sales worth $0 on BCDA, which makes them net buyers over the period. The most recent Form 4 was filed on Jul 15, 26.
The largest recent open-market BCDA insider purchase in our data was $498K by Simon H Stertzer, Director, filed on Sep 19, 25.
3 different insiders at BioCardia, Inc. filed open-market SEC Form 4 transactions on BCDA over the last 12 months.
InsiderTape plots every BCDA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every BioCardia, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →